Stock Events

Stock Events

Sihuan Pharmaceutical Group 

$0.129700
7
-$0.06-30.46% Tuesday 16:23

Statistics

Day High
0.235
Day Low
0.235
52W High
0.235
52W Low
0.1
Volume
50
Avg. Volume
16
Mkt Cap
1.21B
P/E Ratio
0
Dividend Yield
2.15%
Dividend
0

Upcoming

2
JUL
Dividend Ex
Decreased
 
16
JUL
Dividend Payment
Decreased
 
30
SEP
Dividend Ex
Estimated
 
9
OCT
Dividend Payment
Estimated
 
2
JUL 27
Dividend Ex
Estimated
 

Dividends

2.15%Dividend Yield
Jul 26
$0.00
Oct 25
$0.00
Oct 24
$0.00
Jun 23
$0.00
Oct 22
$0.00
10Y Growth
-10.68%
5Y Growth
6.26%
3Y Growth
-16.06%
1Y Growth
99.28%

Earnings

1SepExpected
Q1 2021
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Next
-0
0
0
0.01
Expected EPS
N/A
Actual EPS
N/A

Financials

-11.39%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
521.62MRevenue
-59.4MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SHPHF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
GSK
GSK
Mkt Cap101.54B
GlaxoSmithKline is a global healthcare company that competes in various pharmaceutical sectors, including areas where Sihuan Pharmaceutical operates.
Pfizer
PFE
Mkt Cap143.68B
Pfizer is a large pharmaceutical company with a broad range of products that compete in the same market segments as Sihuan Pharmaceutical.
Novartis
NVS
Mkt Cap280.64B
Novartis is a global healthcare company that offers products in multiple areas, including those where Sihuan Pharmaceutical is active, making it a direct competitor.
Merck
MRK
Mkt Cap281.24B
Merck & Co., Inc. is a leading pharmaceutical company with a diverse product portfolio that competes with Sihuan Pharmaceutical's offerings.
Johnson & Johnson
JNJ
Mkt Cap549.78B
Johnson & Johnson is a healthcare giant that operates in various pharmaceutical niches, competing with Sihuan Pharmaceutical across several product lines.
Sanofi
SNY
Mkt Cap101.45B
Sanofi is a global pharmaceutical company with a wide range of products that compete with Sihuan Pharmaceutical, especially in the areas of cardiovascular and metabolic diseases.
Abbvie
ABBV
Mkt Cap382.49B
AbbVie is a research-based biopharmaceutical company with a strong presence in areas like immunology and oncology, competing with Sihuan Pharmaceutical.
Astrazeneca
AZN
Mkt Cap271.29B
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company with products that compete in the same therapeutic areas as Sihuan Pharmaceutical.
Bristol-Myers Squibb
BMY
Mkt Cap110.27B
Bristol Myers Squibb is a global biopharmaceutical company with a focus on discovering, developing, and delivering innovative medicines that compete with Sihuan Pharmaceutical.
Roche
RHHBY
Mkt Cap320.37B
Roche Holding AG is a healthcare company that engages in the research and development of pharmaceuticals and diagnostics, competing with Sihuan Pharmaceutical in several key areas.

About

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People's Republic of China, the United States, and internationally. It operates in three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The company offers filling, shaping, supporting, supplementing, optoelectronic devices, body sculpturing, skin care, and other services, as well as non- or minimally invasive comprehensive medical aesthetics solutions. It also provides drugs for cardio-cerebral vascular, digestive system, anti-infective, metabolism, respiratory, neurology, oncology, diabetes, and other indications, as well as modern Chinese medicine and industrial hemp products. In addition, the company offers general hospital services. Sihuan Pharmaceutical Holdings Group Ltd. was founded in 2001 and is based in Wan Chai, Hong Kong.
Show more...
CEO
Dr. Fengsheng Che
Employees
2843
Country
Bermuda
ISIN
BMG8162K1137

Listings

STU
DE
TEL1.STU
OTC Link
US
SHPHY
F
DE
TEL1.F
MU
DE
TEL1.MU

0 Comments

Share your thoughts

FAQ

What is Sihuan Pharmaceutical Group stock price today?▼
The current price of SHPHF is $0.13 USD — it has decreased by -30.46% in the past 24 hours. Watch Sihuan Pharmaceutical Group stock price performance more closely on the chart.
What is Sihuan Pharmaceutical Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Sihuan Pharmaceutical Group stocks are traded under the ticker SHPHF.
Is Sihuan Pharmaceutical Group stock price growing?▼
SHPHF stock has fallen by -30.46% compared to the previous week, the month change is a -30.46% fall, over the last year Sihuan Pharmaceutical Group has showed a +29.7% increase.
What is Sihuan Pharmaceutical Group market cap?▼
Today Sihuan Pharmaceutical Group has the market capitalization of 1.21B
When is the next Sihuan Pharmaceutical Group earnings date?▼
Sihuan Pharmaceutical Group is going to release the next earnings report on September 01, 2026.
What is Sihuan Pharmaceutical Group revenue for the last year?▼
Sihuan Pharmaceutical Group revenue for the last year amounts to 521.62M USD.
What is Sihuan Pharmaceutical Group net income for the last year?▼
SHPHF net income for the last year is -59.4M USD.
Does Sihuan Pharmaceutical Group pay dividends?▼
Yes, SHPHF dividends are paid semi-annual. The last dividend per share was 0 USD. As of today, Dividend Yield (FWD)% is 2.15%.
How many employees does Sihuan Pharmaceutical Group have?▼
As of June 28, 2026, the company has 2,843 employees.
In which sector is Sihuan Pharmaceutical Group located?▼
Sihuan Pharmaceutical Group operates in the Health & Wellness sector.
When did Sihuan Pharmaceutical Group complete a stock split?▼
The last stock split for Sihuan Pharmaceutical Group was on June 05, 2014 with a ratio of 2:1.
Where is Sihuan Pharmaceutical Group headquartered?▼
Sihuan Pharmaceutical Group is headquartered in Wan Chai, Bermuda.